Black and Hispanic people get the same benefits from CAR-T therapy as white patients

CAR-T therapy, a form of immunotherapy that revs up T-cells to recognize and destroy cancer cells, has revolutionized the treatment of blood cancers, including certain leukemias, lymphomas, and most recently, multiple myeloma.

Related Keywords

United States ,American ,Amit Verma ,Richard Elkind ,Nishi Shah ,Ira Braunschweig ,Kira Gritsman ,Emily Henderson ,Astha Thakkar ,Mendel Goldfinger ,Aditi Shastri ,Ioannis Mantzaris ,Noah Kornblum ,R Alejandro Sica ,Michelly Abreu ,Eric Feldman ,Cancer Therapeutics Program ,Rn Montefiore Health System ,Albert Einstein College Of Medicine ,Study Co ,Montefiore Health System ,Drug Administration ,National Cancer Montefiore Einstein Center ,Blood Marrow Transplantation ,Albert Einstein College ,African American ,Stem Cell Transplantation ,Cellular Therapy ,Hematologic Malignancies ,Study Co Author ,Health System ,System Senior Vice President ,Kith Pradhan ,Cancer ,Flood ,Fell ,Efficacy ,Wood ,Hospital ,Immunotherapy ,Medicine ,Multiple Myeloma ,Myeloma ,Mh ,Research ,Students ,Herapeutics ,